Information:
Error:
Keywords
Neisseria meningitidis ×
- Clinical Trial (18)
- Haemophilus influenzae type b (18)
- Adverse event (18)
- Vaccines (14)
- Communicable Diseases (9)
- Clinical Trial, Phase III (6)
- Drug-Related Side Effects and Adverse Reactions (5)
- Physical Examination (4)
- Vaccination (4)
- Concomitant Medication (4)
- Eligibility Determination (4)
- Signs and Symptoms (3)
- On-Study Form (3)
- Comparative Study (2)
- Demography (2)
- Drug Administration Routes (2)
- Immunization, Secondary (2)
- Clinical Trial, Phase IV (1)
- Blood (1)
- Haemophilus Vaccines (1)
- Body Temperature (1)
- End of Study (1)
- Exanthema (1)
- Fever (1)
- Follow-Up Studies (1)
- Hematologic Tests (1)
- Informed Consent (1)
- Laboratories (1)
- Medical History Taking (1)
- Parotid Gland (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
18 Search results.
Itemgroups: Administrative data, Temperature Log, Reminder, Rash / Exanthem, Rash Event Log, Parotid/Salivary Gland Swelling Events, Febrile Convulsions - Suspected Signs of Meningitis, Concomitant Vaccination, Concomitant Vaccination Details, Concomitant Medications, Concomitant Medications Details, Non-Serious Adverse Events, Non-Serious Adverse Events Log
Itemgroups: Administrative documentation, Non-Serious Adverse Event
Itemgroups: Administrative documentation, Non-Serious Adverse Event
Itemgroups: Administrative data, Informed Consent, Demographics, Eligibility Check, Inclusion Criteria, Exclusion Criteria, General Medical History / Physical Examination, Meningococcal Vaccination History, Hib Vaccination History, Disease History, Laboratory Tests - Blood, Medication, Vaccine Administration, Vaccine Administration - Vaccine 1, Vaccine Administration - Vaccine 2, Reason for non-administration, Unsolicited Adverse Events, Telephone Contact, Study Conclusion
Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine - 109664 - Visit 1
Itemgroups: Administrative data, Informed Consent, Demographics, Eligibility Check, Inclusion Criteria, Exclusion Criteria, General Medical History / Physical Examination, Meningococcal Vaccination History, Hib Vaccination History, Pertussis Vaccination History, Disease History, Laboratory Tests - Blood, Medication, Study Conclusion, Investigator's Confirmation
Itemgroups: Administrative data, Elimination Criteria During The Study, Contraindications To Subsequent Vaccination, Absolute Contraindications for InfanrixTM-IPV and Aventis PediacelTM Combination Vaccines, Precautions for Vaccination, Informed Consent, Demographics, Eligibility Check, Inclusion Criteria, Exclusion Criteria, Randomisation / Treatment Allocation, Physical Examination, Vaccine History, Laboratory Tests - Blood, Vaccine Administration, Vaccine, Vaccine 2, Non-administration, Unsolicited Adverse Events, Solicited Adverse Events - Local Symptoms, Solicited Adverse Events - Local Symptoms - Vaccine 2, Solicited Adverse Events, General Symptoms
- Hematologic Tests
- Drug-Related Side Effects and Adverse Reactions
- Blood
- Clinical Trial
- Immunization, Secondary
- Clinical Trial, Phase III
- Haemophilus influenzae type b
- Neisseria meningitidis
- Signs and Symptoms
- Vaccination
- Physical Examination
- On-Study Form
- Eligibility Determination
- Adverse event
- Laboratories
Itemgroups: Administrative data, Concomitant Vaccination, Vaccination details, Concomitant Medication, Concomitant Medication Details, Non-Serious Adverse Events, Description of Event, Study Conclusion
Itemgroups: Administrative data, Check for Study Continuation, Elimination Criteria During The Study, Vaccine Administration - Vaccine 1, Vaccine Administration - Vaccine 2, Non-administration, Unsolicited Adverse Events, Solicited Adverse Events - Local Symptoms, Solicited Adverse Events - Local Symptoms - Vaccine 2, Solicited Adverse Events, General Symptoms
Itemgroups: Administrative data, Elimination Criteria During The Study, Contraindications To Subsequent Vaccination, Absolute Contraindications for InfanrixTM-IPV and Aventis PediacelTM Combination Vaccines, Precautions for Vaccination, Informed Consent, Demographics, Eligibility Check, Inclusion Criteria, Exclusion Criteria, Randomisation / Treatment Allocation, Physical Examination, Vaccine History, Laboratory Tests - Blood, Vaccine Administration, Vaccine, Vaccine 2, Non-administration, Unsolicited Adverse Events, Solicited Adverse Events - Local Symptoms, Solicited Adverse Events - Local Symptoms - Vaccine 2, Solicited Adverse Events, General Symptoms
Itemgroups: Adverse Events General Symptoms, Symptoms, Medication
Itemgroups: Adverse Events Symptoms Local, symptoms local
Itemgroups: Adverse Events Symptoms Local, symptoms local